Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
KALA | KALA BIO, Inc. | Common Stock, $0.001 par value per share | 9.99% | $4.23M | 609K | Cormorant Asset Management, LP | Dec 31, 2024 | ||
PRAX | Praxis Precision Medicines, Inc. | Common Stock, par value $0.0001 per share | 9.08% | $65.3M | 1.69M | Cormorant Asset Management, LP | Dec 31, 2024 | ||
BIOA | BioAge Labs, Inc. | Common Stock, par value $0.00001 per share | 7.34% | $11M | 2.63M | Cormorant Asset Management, LP | Dec 31, 2024 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|